Fujii R et al. |
[Clinical studies on clarithromycin dry syrup in the pediatric field. Pediatric Study Group of TE-031 Dry Syrup]. |
1994 |
Jpn J Antibiot |
pmid:7807690
|
Bonnet E et al. |
Clarithromycin: a potent agent against infections due to Mycobacterium marinum. |
1994 |
Clin. Infect. Dis. |
pmid:8038339
|
Lemmen SW et al. |
Bactericidal activity of clarithromycin and cefaclor against Streptococcus pneumoniae and Moraxella catarrhalis in healthy volunteers. |
1994 |
J. Antimicrob. Chemother. |
pmid:8040139
|
Dautzenberg B et al. |
[Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection]. |
1994 |
Rev Mal Respir |
pmid:8041990
|
Böttger EC |
Resistance to drugs targeting protein synthesis in mycobacteria. |
1994 |
Trends Microbiol. |
pmid:7850212
|
al-Assi MT et al. |
Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection. |
1994 |
Am. J. Gastroenterol. |
pmid:8053435
|
Guelar A et al. |
[Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone]. |
1994 |
Enferm. Infecc. Microbiol. Clin. |
pmid:8011719
|
Aspin MM et al. |
Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children. |
1994 |
J. Pediatr. |
pmid:8021763
|
Chaisson RE et al. |
Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team. |
1994 |
Ann. Intern. Med. |
pmid:7978715
|
Goldberger M and Masur H |
Clarithromycin therapy for Mycobacterium avium complex disease in patients with AIDS: potential and problems. |
1994 |
Ann. Intern. Med. |
pmid:7978725
|
Morikawa K et al. |
Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7532933
|
Goldman RC et al. |
Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979278
|
Roblin PM et al. |
Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979292
|
Chan GP et al. |
Clinical trial of clarithromycin for lepromatous leprosy. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8203847
|
Onyeji CO et al. |
Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8203849
|
Bermudez LE et al. |
Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7695252
|
Klemens SP and Cynamon MH |
Intermittent azithromycin for treatment of Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7986001
|
Olliaro P et al. |
In-vitro and in-vivo activity of rifabutin against Toxoplasma gondii. |
1994 |
J. Antimicrob. Chemother. |
pmid:7706160
|
Cynamon MH et al. |
Comparative activities of azithromycin and clarithromycin against Mycobacterium avium infection in beige mice. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7979270
|
Marco ML et al. |
[Rhodococcus equi pneumonia in patients with AIDS]. |
1994 |
Arch. Bronconeumol. |
pmid:7827773
|
Rapp RP et al. |
New macrolide antibiotics: usefulness in infections caused by mycobacteria other than Mycobacterium tuberculosis. |
1994 |
Ann Pharmacother |
pmid:7849341
|
Ji B et al. |
Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7872741
|
Skinner PS et al. |
A bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditions. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7872747
|
Valero G et al. |
Activities of clarithromycin, ofloxacin, and clarithromycin plus ethambutol against Mycobacterium simiae in murine model of disseminated infection. |
1994 |
Antimicrob. Agents Chemother. |
pmid:7872769
|
Yamada S et al. |
[A child with iritis due to Chlamydia pneumoniae infection]. |
1994 |
Kansenshogaku Zasshi |
pmid:7876679
|
Wüst J and Hardegger U |
Penetration of clarithromycin into human saliva. |
1993 Sep-Oct |
Chemotherapy |
pmid:8370320
|
Scaglione F et al. |
A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells. |
1993 Nov-Dec |
Chemotherapy |
pmid:8222870
|
Ohmori S et al. |
Effects of clarithromycin and its metabolites on the mixed function oxidase system in hepatic microsomes of rats. |
1993 Mar-Apr |
Drug Metab. Dispos. |
pmid:8097709
|
Wallace RJ et al. |
Drug intolerance to high-dose clarithromycin among elderly patients. |
1993 Mar-Apr |
Diagn. Microbiol. Infect. Dis. |
pmid:8477575
|
Adam D |
Clarithromycin 250 mg b.i.d. for 5 or 10 days in the treatment of adult patients with purulent bronchitis. |
1993 Jul-Aug |
Infection |
pmid:8225636
|
Coles SJ et al. |
A comparative study of clarithromycin and amoxycillin suspensions in the treatment of pediatric patients with acute otitis media. |
1993 Jul-Aug |
Infection |
pmid:8225637
|
Miller CA |
Infections, resistant microbes, and older adults. |
1993 Jan-Feb |
Geriatr Nurs |
pmid:8383085
|
Ritchie DJ et al. |
In vitro activity of clarithromycin, cefprozil, and other common oral antimicrobial agents against gram-positive and gram-negative pathogens. |
1993 Jan-Feb |
Clin Ther |
pmid:8458040
|
Albani F et al. |
Clarithromycin-carbamazepine interaction: a case report. |
1993 Jan-Feb |
Epilepsia |
pmid:8422851
|
Sader HS et al. |
In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers. |
1993 Aug-Sep |
Diagn. Microbiol. Infect. Dis. |
pmid:8243035
|
De Wit S et al. |
Acquired resistance to clarithromycin as combined therapy in Mycobacterium avium intracellulare infection. |
1993 |
Lancet |
pmid:8093299
|
Maurin M and Raoult D |
In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8109928
|
Parish LC |
Clarithromycin in the treatment of skin and skin structure infections: two multicenter clinical studies. Clarithromycin Study Group. |
1993 |
Int. J. Dermatol. |
pmid:8340194
|
|
Clarithromycin effectively treats infection in AIDS patients. |
1993 |
Oncology (Williston Park, N.Y.) |
pmid:8512782
|
Clark JA and Margolis DM |
A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex. |
1993 |
Clin. Infect. Dis. |
pmid:8513064
|
Alba D et al. |
[Clarithromycin in the treatment of cerebral toxoplasmosis associated with HIV infection]. |
1993 |
Rev Clin Esp |
pmid:8516514
|
Alder J et al. |
Clarithromycin therapy of experimental Treponema pallidum infections in hamsters. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8494384
|
Humphreys JE et al. |
A clarithromycin sensitivity survey in the United Kingdom using Stokes' method. |
1993 |
J. Antimicrob. Chemother. |
pmid:8226438
|
Franck N et al. |
Treatment of Mycobacterium chelonae-induced skin infection with clarithromycin. |
1993 |
J. Am. Acad. Dermatol. |
pmid:8496448
|
Scaglione F et al. |
Immunostimulation by clarithromycin in healthy volunteers and chronic bronchitis patients. |
1993 |
J Chemother |
pmid:8229150
|
Tomioka H et al. |
[In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice]. |
1993 |
Kekkaku |
pmid:8497119
|
Andrews J and Wise R |
Disk susceptibility testing for clarithromycin. |
1993 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:8187799
|
Calhoun KH and Hokanson JA |
Multicenter comparison of clarithromycin and amoxicillin in the treatment of acute maxillary sinusitis. |
1993 |
Arch Fam Med |
pmid:8111512
|
Saint-Marc T et al. |
[Mycobacterium avium intracellulare infections. Treatment with a clarithromycin-clofazimine combination. 18 cases]. |
1993 |
Presse Med |
pmid:8121903
|
Akiyama H et al. |
Interaction of Staphylococcus aureus cells and silk threads in vitro and in mouse skin. |
1993 |
J. Dermatol. Sci. |
pmid:8136322
|
Granier H et al. |
[Mycobacterium chelonei arthritis in an immunosuppressed patient. Efficacy of the treatment with clarithromycin]. |
1993 |
Ann Med Interne (Paris) |
pmid:8141516
|
MacGowan AR et al. |
Synergy testing of macrolide combinations using the chequerboard technique. |
1993 |
J. Antimicrob. Chemother. |
pmid:8144439
|
Vaara M |
Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8383945
|
Ximenes E et al. |
[Ciprofloxacin, clarithromycin, rifampin: in vitro bactericidal activity of double and triple drug combinations against strains of atypical mycobacteria]. |
1993 |
Pathol. Biol. |
pmid:8233629
|
Peterson WL et al. |
Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. |
1993 |
Am. J. Gastroenterol. |
pmid:8237933
|
Romand S et al. |
In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285620
|
Yasuda H et al. |
Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239580
|
Schmidt T et al. |
Clarithromycin lacks bactericidal activity in cerebrospinal fluid in experimental pneumococcal meningitis. |
1993 |
J. Antimicrob. Chemother. |
pmid:8288505
|
Dautzenberg B et al. |
Clarithromycin and other antimicrobial agents in the treatment of disseminated Mycobacterium avium infections in patients with acquired immunodeficiency syndrome. |
1993 |
Arch. Intern. Med. |
pmid:8427539
|
Walker LL et al. |
Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin. |
1993 |
Int. J. Lepr. Other Mycobact. Dis. |
pmid:8326182
|
Alder J et al. |
Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8328782
|
Mor N and Heifets L |
Inhibition of intracellular growth of Mycobacterium avium by one pulsed exposure of infected macrophages to clarithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8328792
|
Lazard T et al. |
Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215285
|
Helm CJ et al. |
Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model. |
1993 |
Am. J. Ophthalmol. |
pmid:8250072
|
Green PA et al. |
Mycobacterium avium complex parotid lymphadenitis: successful therapy with clarithromycin and ethambutol. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8346008
|
Pialoux G et al. |
Combination antibiotic treatment with clarithromycin for human immunodeficiency virus-associated Rhodococcus equi infection. |
1993 |
Clin. Infect. Dis. |
pmid:8218702
|
|
Clinical Perspectives on Clarithromycin in Pediatric Infections. Symposium proceedings. February 19-20, 1993. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:7905199
|
Foltzer MA et al. |
Bronchopulmonary bacillary angiomatosis. |
1993 |
Chest |
pmid:8365330
|
Fraschini F et al. |
Clarithromycin clinical pharmacokinetics. |
1993 |
Clin Pharmacokinet |
pmid:8222460
|
Neu HC and Chick TW |
Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections. |
1993 |
Chest |
pmid:8222794
|
Sedlmayr T et al. |
[Clarithromycin, a new macrolide antibiotic. Effectiveness in puerperal infections and pharmacokinetics in breast milk]. |
1993 |
Geburtshilfe Frauenheilkd |
pmid:8370491
|
Kodama R et al. |
[Eradication therapy of Helicobacter pylori in gastroduodenal ulcer and its long-term course]. |
1993 |
Nippon Rinsho |
pmid:8283646
|
Chien SM et al. |
Treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing clarithromycin with erythromycin. Canada-Sweden Clarithromycin-Pneumonia Study Group. |
1993 |
Chest |
pmid:8449054
|
Watanabe Y et al. |
Chemical modification of erythromycins. IX. Selective methylation at the C-6 hydroxyl group of erythromycin A oxime derivatives and preparation of clarithromycin. |
1993 |
J. Antibiot. |
pmid:8501007
|
Roig J et al. |
Treatment of Legionnaires' disease. Current recommendations. |
1993 |
Drugs |
pmid:7691508
|
Still JG et al. |
Comparison of clarithromycin and penicillin VK suspensions in the treatment of children with streptococcal pharyngitis and review of currently available alternative antibiotic therapies. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8295815
|
Craft JC and Siepman N |
Overview of the safety profile of clarithromycin suspension in pediatric patients. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8295816
|
Klein JO |
Clarithromycin: where do we go from here? |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8295817
|
Hardy DJ |
Extent and spectrum of the antimicrobial activity of clarithromycin. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8295818
|
Dubois J et al. |
Efficacy of clarithromycin vs. amoxicillin/clavulanate in the treatment of acute maxillary sinusitis. |
1993 |
Ear Nose Throat J |
pmid:8313865
|
Nasu M |
[Helicobacter pylori infections]. |
1993 |
Nippon Naika Gakkai Zasshi |
pmid:8315343
|
Braga PC and Piatti G |
Sub-lethal concentrations of clarithromycin interfere with the expression of Staphylococcus aureus adhesiveness to human cells. |
1993 |
J Chemother |
pmid:8371124
|
Macklin JL et al. |
A single-blind, randomised, comparative study of clarithromycin and amoxycillin suspensions in the treatment of children with lower respiratory tract infections. |
1993 |
J Chemother |
pmid:8371127
|
Ragnaud JM et al. |
[Cerebral toxoplasmosis in AIDS. 73 cases. Clinical Epidemiology Group on AIDS in Aquitania]. |
1993 |
Presse Med |
pmid:8378280
|
Hoffner SE et al. |
Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8392308
|
Gevaudan MJ et al. |
In-vitro evaluation of clarithromycin, temafloxacin, and ethambutol in combination against Mycobacterium avium complex. |
1993 |
J. Antimicrob. Chemother. |
pmid:8392998
|
Wallace RJ et al. |
Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. |
1993 |
Ann. Intern. Med. |
pmid:8357113
|
Wettengel R et al. |
Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis. |
1993 |
J. Antimicrob. Chemother. |
pmid:8360133
|
Nakashio S et al. |
[Antimicrobial activity of clarithromycin and its effect on bacterial adherence to medical material]. |
1993 |
Jpn J Antibiot |
pmid:8360978
|
Lonks JR and Medeiros AA |
High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R.I. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239578
|
Mor N and Heifets L |
MICs and MBCs of clarithromycin against Mycobacterium avium within human macrophages. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8431006
|
Tomioka H et al. |
In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8431020
|
Chu SY et al. |
Effect of moderate or severe hepatic impairment on clarithromycin pharmacokinetics. |
1993 |
J Clin Pharmacol |
pmid:8331208
|
Guay DR et al. |
Overview of the tolerability profile of clarithromycin in preclinical and clinical trials. |
1993 |
Drug Saf |
pmid:8504017
|
Dever LL et al. |
Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215288
|
Fass RJ |
Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8257127
|
Holdcroft C |
Two new macrolide antibiotics: clarithromycin and azithromycin. |
1993 |
Nurse Pract |
pmid:8380492
|
Dempsey CL et al. |
Drug usage evaluation: clarithromycin as sequential therapy. |
1993 |
Hosp Formul |
pmid:10130382
|
Goldstein EJ and Citron DM |
Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8390810
|
Watanabe Y et al. |
Chemical modification of erythromycins. XII. A facile synthesis of clarithromycin (6-O-methylerythromycin A) via 2'-silylethers of erythromycin A derivatives. |
1993 |
J. Antibiot. |
pmid:8360112
|